Watch for Eysuvis to Treat Dry Eyes

Rx Eysuvis (loteprednol 0.25% suspension) will be the first FDA-approved ophthalmic corticosteroid for treating dry eyes.

But it's only for up to 2 weeks of use.

Point out that long-term use of any ophthalmic steroid can increase the risk of glaucoma or cataracts...regardless of the steroid, strength, or formulation.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote